A detailed history of Payden & Rygel transactions in Cme Group Inc. stock. As of the latest transaction made, Payden & Rygel holds 2,600 shares of CME stock, worth $615,732. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,600
Previous 32,300 91.95%
Holding current value
$615,732
Previous $6.35 Million 90.96%
% of portfolio
0.04%
Previous 0.51%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$193.43 - $220.62 $5.74 Million - $6.55 Million
-29,700 Reduced 91.95%
2,600 $574,000
Q2 2024

Oct 07, 2024

BUY
$194.1 - $216.77 $5.76 Million - $6.44 Million
29,700 Added 1142.31%
32,300 $6.35 Million
Q1 2024

Oct 08, 2024

SELL
$196.4 - $221.35 $5.83 Million - $6.57 Million
-29,700 Reduced 91.95%
2,600 $560,000
Q4 2023

Feb 12, 2024

SELL
$200.15 - $220.06 $14.6 Million - $16.1 Million
-73,000 Reduced 96.56%
2,600 $548,000
Q2 2023

Aug 10, 2023

BUY
$176.67 - $195.19 $13.4 Million - $14.8 Million
75,600 New
75,600 $14 Million

Others Institutions Holding CME

About CME GROUP INC.


  • Ticker CME
  • Exchange NASDAQ
  • Sector Financial Services
  • Industry Financial Data & Stock Exchanges
  • Shares Outstandng 359,432,992
  • Market Cap $85.1B
  • Description
  • CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provide...
More about CME
Track This Portfolio

Track Payden & Rygel Portfolio

Follow Payden & Rygel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Payden & Rygel, based on Form 13F filings with the SEC.

News

Stay updated on Payden & Rygel with notifications on news.